REQUEST A DEMO
Total
USD $0.00
Search more companies

Medison Pharma Sp. z o.o. (Poland)

Main Activities: Administrative Management and General Management Consulting Services
Full name: Medison Pharma Sp. z o.o. Profile Updated: August 24, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Medison Pharma Sp. z o.o. is an enterprise in Poland, with the main office in Warsaw. The company operates in the Administrative Management and General Management Consulting Services industry. It was incorporated on August 06, 2020. The latest financial highlights indicate a net sales revenue increase of 62.39% in 2023. Its’ total assets recorded a growth of 120.68%. The enterprise’s net profit margin decreased by 0.09% in 2023.

Headquarters
Ul. Hrubieszowska 2
Warsaw; Mazowieckie; Postal Code: 01-209

Contact Details: Purchase the Medison Pharma Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Medison Pharma Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Medison Pharma Sp. z o.o. report to view the information.
Incorporation Date:
August 06, 2020
Key Executives
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Medison Pharma Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
62.39%
Total operating revenue
62.57%
Operating profit (EBIT)
62.08%
EBITDA
99.49%
Net Profit (Loss) for the Period
59.37%
Total assets
120.68%
Total equity
143.27%
Operating Profit Margin (ROS)
-0.01%
Net Profit Margin
-0.09%
Return on Equity (ROE)
-31.08%
Quick Ratio
-0.1%
Cash Ratio
-0.12%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?